Sponsor Pipeline

Yantai Yuhuangding Hospital Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
4
Disease Areas
Active Trials by Phase
Phase 2
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07054242 A Prospective, Single-center, Phase II Study of Sacituzumab Tirumotecan in Combination… Neoadjuvant Therapy Not Yet Recruiting
Not specified
NCT06499818 CPVI Alone Versus CPVI Plus Low-Voltage Areas Ablation During SR Versus CPVI Plus… Atrial Fibrillation Not Yet Recruiting
NCT07586501 China-NINE Cohort：Neuroimmune Network in Elderly / Neurodegeneration Cognitive Dysfunction Enrolling by Invitation
Disease Areas
Atrial Fibrillation (1) Breast Cancer (1) Triple-Negative Breast Cancer (1) Parkinson's Disease (1)
Get alerts when Yantai Yuhuangding Hospital's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free